Friday, March 24, 2017
Invitae announces expansion of its genetic testing offering to include unique test for Spinal Muscular Atrophy (SMA) during the 2017 ACMG Annual Clinical Genetics Meeting
SAN FRANCISCO, March 22, 2017 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced the availability of a new genetic test for the diagnosis of
Advisory - Unauthorized products seized from EPCA Shipping Inc. in Richmond, British Columbia, may pose serious health risks
OTTAWA, March 21, 2017 /CNW/ - Issue
Health Canada is advising Canadians that it has seized several unauthorized health products from EPCA Shipping Inc. at 1115-11871 Horseshoe Way, Richmond BC (see list below). The products are promoted to treat can.....
26 Year Old Bryan Alzate Opens Drug Rehab in South Florida
NEW YORK, March 21, 2017 /PRNewswire-iReach/ -- FOR IMMEDIATE RELEASE -- United Recovery Project, announces the launch of their new prestigious and comprehensive rehabilitation center in Hollywood, Florida. Established in 2016 CEO and Co-Founder, Bryan Alzate
Missing Pieces of the 'Health Care' Debate
CORTE MADERA, Calif., March 21, 2017 /PRNewswire/ -- Dr. Don Harte, noted chiropractic activist and former Libertarian State Senate candidate, knows that the current debate on so-called 'health care' is wrong, on all sides.

Neurocrine Announces American Journal of Psychiatry Publication of Positive Results from Kinect 3 Phase III Study of INGREZZA TM (valbenazine) for the Treatment of Tardive Dyskinesia
SAN DIEGO, March 21, 2017 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a biotechnology company focused on neurologic, psychiatric and endocrine related disorders, announced today that positive results from the Kinect 3 Phase III study of INGREZZA (valbenazine) for the treatment of tardive dyskinesia (TD) were .....
AMITA Health Offers Unique Opportunity For Medicare Recipients To Determine Whether They Have Alzheimer's
ARLINGTON HEIGHTS, Ill., March 21, 2017 /PRNewswire/ -- AMITA Health is offering a unique opportunity for Medicare recipients with mild memory loss, cognitive impairment or dementia to undergo at minimal expense a diagnostic test for Alzheimer's disease that usually costs thousands of dollars.
COPD Inhalers Market will Reach 61.3 Billion by 2022 with a CAGR of 5.3% from 2016
Brisbane, Queensland, Australia - March 21st, 2017 - Whether you have been out of the workforce for some time or simply looking for a career...
Sound Pharmaceuticals announces $1.6 Million Award from Cystic Fibrosis Foundation Therapeutics to prevent and treat the hearing loss and tinnitus associated with antibiotic use
SEATTLE, March 21, 2017 /PRNewswire/ -- Sound Pharmaceuticals, Inc., (SPI) is pleased to announce that it has been awarded up to $1.6M from Cystic Fibrosis Foundation Therapeutics Inc. (CFFT), the non-profit drug discovery and development affiliate of the Cystic Fibrosis Foundation. The CFFT deve.....
NephCure Kidney InternationalŽ Launches the NephCure Accelerating Cures InstituteŽ
KING OF PRUSSIA, Pa., March 21, 2017 /PRNewswire-USNewswire/ -- With a goal of bringing more effective treatments for rare glomerular kidney diseases (including Focal Segmental Glomerulosclerosis (FSGS), Minimal Change Disease (MCD), IgA Nephropathy, and Membranous Nephropathy) to the market faster, NephCure Kidney Internatio.....


About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines